| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.3 | 0.08 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |